Rigrodsky & Long, P.A. Announces Investigation Of Palomar Medical Technologies, Inc. Buyout
18 3월 2013 - 11:26PM
Business Wire
Rigrodsky & Long, P.A.:
- Do you own shares of Palomar Medical
Technologies, Inc. (NASDAQ GS: PMTI)?
- Did you purchase any of your shares
prior to March 18, 2013?
- Do you think the proposed buyout
price is too low?
- Do you want to discuss your
rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of Palomar
Medical Technologies, Inc. (“Palomar” or the “Company”) (NASDAQ GS:
PMTI) regarding possible breaches of fiduciary duties and other
violations of law related to the Company’s entry into an agreement
to be acquired by Cynosure, Inc. (“Cynosure”) (NASDAQ GS: CYNO) in
a transaction valued at approximately $294 million.
Click here to learn more:
http://www.rigrodskylong.com/investigations/palomar-medical-technologies-inc-pmti.
Under the terms of the proposal, public shareholders of Palomar
will receive $13.65 per share of Palomar common stock: $6.825 per
share in cash and $6.825 per share in Cynosure common stock.
The investigation concerns whether Palomar’s board of directors
failed to adequately shop the Company and obtain the best possible
value for Palomar’s shareholders before entering into an agreement
with Cynosure. According to Yahoo! Finance, at least one analyst
has set a price target for Palomar stock at $14.50 per share.
If you own the common stock of Palomar and purchased your shares
before March 18, 2013, if you have information or would like to
learn more about these claims, or if you wish to discuss these
matters or have any questions concerning this announcement or your
rights or interests with respect to these matters, please contact
Seth Rigrodsky or Brian Long at Rigrodsky & Long, P.A., 2
Righter Parkway, Suite 120, Wilmington, Delaware 19803, by
telephone at (302) 295-5310, or Peter Allocco at Rigrodsky &
Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New
York 11530, by telephone at (888) 969-4242; by e-mail to
info@rigrodskylong.com, or at:
http://www.rigrodskylong.com/investigations/palomar-medical-technologies-inc-pmti.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware
and Garden City, New York, regularly prosecutes securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in
states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Palomar Medical Technologies, Inc. (MM) (NASDAQ:PMTI)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024